Silo Pharma acquires 'Reputation Endpoints' software from Larry King for 150,000 shares

Silo Pharma, Inc.

Asset purchase agreement dated Oct 13, 2026: Silo Pharma buys the source and object code for web-based tools marketed as 'Reputation Endpoints' plus all related IP.
Purchase price is 150,000 shares of common stock ($0.0001 par), delivered within five business days; Seller delivers the software within three days of receipt.
Shares are locked up for 12 months, ending earlier upon a Change in Control or the Company's written consent.
Larry King indemnifies for misrepresentation, third-party infringement, gross negligence or fraud; liability capped at the fair market value of the 150,000 shares; reps survive 12 months.
Seller warrants the software is original, free of malicious code, has no undisclosed open-source components, and that he is exclusive owner free of liens or prior licenses.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.